Ubs Asset Management Americas Inc Neogenomics Inc Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 581,787 shares of NEO stock, worth $5.29 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
581,787
Previous 497,451
16.95%
Holding current value
$5.29 Million
Previous $4.72 Million
9.92%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding NEO
# of Institutions
307Shares Held
129MCall Options Held
1.17MPut Options Held
297K-
Black Rock Inc. New York, NY19.7MShares$179 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$129 Million0.0% of portfolio
-
Greenhouse Funds Lllp Baltimore, MD7.43MShares$67.6 Million2.32% of portfolio
-
First Light Asset Management, LLC Edina, MN6.85MShares$62.3 Million7.69% of portfolio
-
State Street Corp Boston, MA5.11MShares$46.5 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.14B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...